Juno Therapeutics, Inc. (JUNO) has 73 open-market insider trades by 15 insiders since 2004. The most active filer is John P. Pecora, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Crestline Investors, Inc. | 10% Owner | — | 2 | $551.4M | 2017-07-13 |
| Douglas K. Bratton | 10% | — | 3 | $31.0M | 2015-07-02 |
| Hans Edgar Bishop | CEOPres | — | 8 | $30.3M | 2018-03-05 |
| John P. Pecora | 10% | — | 16 | $19.0M | 2005-06-30 |
| Si (gp) L.p. Crestline | 10% | — | 1 | $15.6M | 2014-12-23 |
| Robert Azelby | CCOVP | — | 10 | $13.7M | 2018-03-05 |
| Richard Klausner | Dir | — | 11 | $7.2M | 2018-03-05 |
| Steve Harr | CFO | — | 6 | $3.5M | 2018-03-05 |
| Hal Barron | Dir | — | 1 | $2.4M | 2018-03-05 |
| Bernard J. Cassidy | CLOSecretary | — | 7 | $1.9M | 2018-03-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Azelby | EVP & Chief Commercial Officer | Sell | $356K | 2018-02-12 |
| Robert Azelby | CCO & VP | Sell | $712K | 2018-02-12 |
| Robert Azelby | CCO & VP | Sell | $600K | 2018-02-08 |
| Robert Azelby | CCO & VP | Sell | $715K | 2018-02-01 |
| Robert Azelby | CCO & VP | Sell | $17.7M | 2018-01-22 |
| Robert Azelby | CCO & VP | Sell | $4.0M |
Companies that share insiders with JUNO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-01-17 |
| Hans Edgar Bishop | CEO & President | Sell | $25.0M | 2018-01-16 |
| Richard Klausner | Director | Sell | $1.2M | 2018-01-08 |
| Richard Klausner | Director | Sell | $3.2M | 2017-12-21 |
| Steve Harr | CFO | Sell | $392K | 2017-12-21 |
| Robert Azelby | CCO & VP | Sell | $163K | 2017-12-18 |
| Robert Azelby | CCO & VP | Sell | $733K | 2017-11-02 |
| Sunil Agarwal | President | Sell | $652K | 2017-10-02 |
| Bernard J. Cassidy | CLO & Secretary | Sell | $2.5M | 2017-09-14 |
| Robert Azelby | CCO & VP | Sell | $1.2M | 2017-09-13 |